Crossref journal-article
Springer Science and Business Media LLC
Oncogene (297)
Bibliography

Sebolt-Leopold, J. S. (2000). Development of anticancer drugs targeting the MAP kinase pathway. Oncogene, 19(56), 6594–6599.

Authors 1
  1. Judith S Sebolt-Leopold (first)
References 75 Referenced 259
  1. Alessi DR, Cuenda A, Cohen P, Dudley DT and Saltiel AR. . 1995 J. Biol. Chem. 270: 27489–27494. (10.1074/jbc.270.46.27489)
  2. Allen M, Svensson L, Roach M, Hambor J, McNeish J and Gabel CA. . 2000 J. Exp. Med. 191: 859–869. (10.1084/jem.191.5.859)
  3. Anderson NG, Maller JL, Tonks NK and Sturgill TW. . 1990 Nature 343: 651–653. (10.1038/343651a0)
  4. Bayer Corporation. . 1999a WO9932106.
  5. Bayer Corporation. . 1999b WO9932436.
  6. Bayer Corporation. . 1999c WO9932455.
  7. Bayer Corporation. . 2000 WO200042012. (10.1016/S0262-1762(00)90235-9)
  8. Boucher MJ, Morisset J, Vachon PH, Reed JC, Laine J and Rivard N. . 2000 J. Cell. Biochem. 79: 355–369. (10.1002/1097-4644(20001201)79:3<355::AID-JCB20>3.0.CO;2-0)
  9. Brunet A, Pages G and Pouyssegur J. . 1994 FEBS Lett. 346: 299–303. (10.1016/0014-5793(94)00475-7)
  10. Chen Q, Kinch MS, Lin TH, Burridge K and Juliano RL. . 1994 J. Biol. Chem. 269: 26602–26605. (10.1016/S0021-9258(18)47058-5)
  11. Cobb MH. . 1999 Prog. Biophys. Mol. Biol. 71: 479–500. (10.1016/S0079-6107(98)00056-X)
  12. Cowley S, Paterson H, Kemp P and Marshall CJ. . 1994 Cell 77: 841–852. (10.1016/0092-8674(94)90133-3)
  13. Crews CM, Alessandrini A and Erikson RL. . 1992 Science 258: 478–480. (10.1126/science.1411546)
  14. Daum G, Eisenmann-Tappe I, Fries HW, Troppmair J and Rapp UR. . 1994 Trends Biochem. Sci. 19: 474–480. (10.1016/0968-0004(94)90133-3)
  15. Dent P, Haser W, Haystead TA, Vincent LA, Roberts TM and Sturgill TW. . 1992 Science 257: 1404–1407. (10.1126/science.1326789)
  16. Dudley DT, Pang L, Decker SJ, Bridges AJ and Saltiel AR. . 1995 Proc. Natl. Acad. Sci. USA 92: 7686–7689. (10.1073/pnas.92.17.7686)
  17. Eliceiri BP, Klemke R, Stromblad S and Cheresh DA. . 1998 J. Cell Biol. 141: 1255–1263. (10.1083/jcb.140.5.1255)
  18. Fang X, Yu S, Eder A, Mao M, Bast Jr RC, Boyd D and Mills GB. . 1999 Oncogene 18: 6635–6640. (10.1038/sj.onc.1203076)
  19. Fincham VJ, James M, Frame MC and Winder SJ. . 2000 EMBO J. 19: 2911–2923. (10.1093/emboj/19.12.2911)
  20. Finlay D, Healy V, Furlong F, O'Connell FC, Keon NK and Martin F. . 2000 Cell Death Differ. 7: 303–313. (10.1038/sj.cdd.4400652)
  21. Gille H, Sharrocks AD and Shaw PE. . 1992 Nature 258: 414–417. (10.1038/358414a0)
  22. Gioeli D, Mandell JW, Petroni GR, Frierson Jr HF and Weber MJ. . 1999 Cancer Res. 59: 279–284.
  23. Giroux S, Tremblay M, Bernard D, Cardin-Girard JF, Aubry S, Larouche L, Rousseau S, Huot J, Landry J, Jeannotte L and Charon J. . 1999 Curr. Biol. 9: 369–372. (10.1016/S0960-9822(99)80164-X)
  24. Hagemann C and Rapp UR. . 1999 Exp. Cell Res. 253: 34–46. (10.1006/excr.1999.4689)
  25. Hall-Jackson CA, Eyers PA, Cohen P, Goedert M, Boyle FT, Hewitt NH and Hedge P. . 1999 Chem. Biol. 6: 559–568. (10.1016/S1074-5521(99)80088-X)
  26. Henry SP, Monteith D, Bennett F and Levin AA. . 1997 Anticancer Drug Des. 12: 409–420.
  27. Her JH, Lakhani S, Zu K, Vila J, Dent P, Sturgill TW and Weber MJ. . 1993 Biochem. J. 296: 25–31. (10.1042/bj2960025)
  28. Herrera R. . 1998 J. Cell Science 111: 1039–1049. (10.1242/jcs.111.8.1039)
  29. Hill CS and Treisman R. . 1995 Cell 80: 199–211. (10.1016/0092-8674(95)90403-4)
  30. Holmstrom TH, Tran SE, Johnson VL, Ahn NG, Chow SC and Eriksson JE. . 1999 Mol. Cell. Biol. 19: 5991–6002. (10.1128/MCB.19.9.5991)
  31. Hoshino R, Chatani Y, Yamori T, Tsuruo T, Oka H, Yoshida O, Shimada Y, Ari-I S, Wada H, Fujimoto J and Kohno M. . 1999 Oncogene 18: 813–822. (10.1038/sj.onc.1202367)
  32. Janknect R, Ernst WH, Pingoud V and Nordheim A. . 1993 EMBO J. 12: 5097–5104. (10.1002/j.1460-2075.1993.tb06204.x)
  33. Kolch W. . 2000 Biochem. J. 351: 289–305. (10.1042/bj3510289)
  34. Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, Finkenzeller G, Marme D and Rapp UR. . 1993 Nature 364: 249–252. (10.1038/364249a0)
  35. Lange CA, Richer JK, Shan T and Horwitz KB. . 1996 J. Biol. Chem. 273: 31308–31316. (10.1074/jbc.273.47.31308)
  36. Lee SW, Fang L, Igarashi M, Ouchi T, Lu KP and Aaronson SA. . 2000 Proc. Natl. Acad. Sci. USA 97: 8302–8305. (10.1073/pnas.150024397)
  37. Lenormand P, Brondello JM, Brunet A and Pouyssegur J. . 1998 J. Cell. Biol. 142: 625–633. (10.1083/jcb.142.3.625)
  38. Lewis TS, Shapiro PS and Ahn NG. . 1998 Adv. Cancer Res. 74: 49–139. (10.1016/S0065-230X(08)60765-4)
  39. Li W, Han M and Guan K-L. . 2000 Genes Dev. 14: 895–900. (10.1101/gad.14.8.895)
  40. Lu H-T, Yang DD, Wysk M, Gatti E, Mellman I, Davis RJ and Flavell RA. . 1999 EMBO J. 18: 1845–1857. (10.1093/emboj/18.7.1845)
  41. Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF and Ahn NG. . 1994 Science 265: 966–970. (10.1126/science.8052857)
  42. Marais R, Wynne J and Treisman R. . 1993 Cell 73: 381–393. (10.1016/0092-8674(93)90237-K)
  43. McDonald OB, Chen WJ, Ellis B, Hoffman C, Overton L, Rink M, Smith A, Marshall CJ and Wood ER. . 1999 Anal. Biochem. 268: 318–329. (10.1006/abio.1998.3030)
  44. Milanini J, Vinals F, Pouyssegur J and Pages G. . 1998 J. Biol. Chem. 273: 18165–18172. (10.1074/jbc.273.29.18165)
  45. Monia BP, Johnston JF, Geiger T, Muller M and Fabbro D. . 1996 Nature Med. 2: 668–675. (10.1038/nm0696-668)
  46. O'Dwyer PJ, Stevenson JP, Gallagher M, Cassella A, Vasilevskaya I, Monia BP, Holmlund J, Dorr FA and Yao KS. . 1999 Clin. Cancer Res. 5: 3977–3982.
  47. Pages G, Lenorman D, L'Allemain G, Chambard JC, Meloche S and Pouyssegur J. . 1993 Proc. Natl. Acad. Sci. USA. 90: 8319–8323. (10.1073/pnas.90.18.8319)
  48. Pages G, Guerin S, Grall D, Bonino F, Smith A, Anjuere F, Auberger P and Pouyssegur J. . 1999 Science 286: 1374–1377. (10.1126/science.286.5443.1374)
  49. Pang L, Sawada T, Decker SJ and Saltiel AR. . 1995 J. Biol. Chem. 270: 13585–13588. (10.1074/jbc.270.23.13585)
  50. Persons DL, Yazlovitskaya EM, Cui W and Pelling JC. . 1999 Clin. Cancer Res. 5: 1007–1014.
  51. Persons DL, Yazlovitskaya EM and Pelling JC. . 2000 J. Biol. Chem. in press.
  52. Petit AM, Rak J, Hung MC, Rockwell P, Goldstein N, Fendly B and Kerbel RS. . 1997 Am. J. Pathol. 151: 1523–1530.
  53. Potempa S and Ridley AJ. . 1998 Mol. Biol. Cell. 9: 2185–2200. (10.1091/mbc.9.8.2185)
  54. Ridley AJ, Comoglio PM and Hall A. . 1995 Mol. Cell Biol. 15: 1110–1122. (10.1128/MCB.15.2.1110)
  55. Schaeffer HJ, Catling AD, Eblen ST, Collier LS, Krauss A and Weber MJ. . 1998 Science 281: 1668–1671. (10.1126/science.281.5383.1668)
  56. Scheid MP, Schubert KM and Duronio V. . 1999 J. Biol. Chem. 274: 31108–31113. (10.1074/jbc.274.43.31108)
  57. Sebolt-Leopold JS, Dudley DT, Herrera R, Van Becelaere K, Wiland A, Gowan RC, Tecle H, Barrett SD, Bridges A, Przybranowski S, Leopold WR and Saltiel AR. . 1999 Nature Med. 5: 810–816. (10.1038/10533)
  58. Seger R, Ahn NG, Posada J, Munar ES, Jensen AM, Cooper JA, Cobb MH and Krebs EG. . 1992 J. Biol. Chem. 267: 14373–14381. (10.1016/S0021-9258(19)49722-6)
  59. Stanton Jr VP and Cooper GM. . 1987 Mol. Cell. Biol. 7: 1171–1179. (10.1128/mcb.7.3.1171-1179.1987)
  60. Stevenson JP, Yao K-S, Gallagher M, Friedland D, Mitchell EP, Cassella A, Monia B, Kwoh TJ, Yu R, Holmlund J, Dorr FA and O'Dwyer PJ. . 1999 J. Clin. Oncol. 17: 2227–2236. (10.1200/JCO.1999.17.7.2227)
  61. Stewart S, Sundaram M, Zhang Y, Lee J, Han M and Guan K-L. . 1999 Mol. Cell. Biol. 19: 5523–5534. (10.1128/MCB.19.8.5523)
  62. Stokoe D, Macdonald SG, Cadwallader K, Symons M and Hancock JF. . 1994 Science 264: 1463–1467. (10.1126/science.7811320)
  63. Storm SM and Rapp UR. . 1993 Toxicol. Lett. 67: 201–210. (10.1016/0378-4274(93)90056-4)
  64. Tanimura S, Chatani Y, Hoshino R, Sato M, Watanabe S, Kataoka T, Nakamura T and Kohno M. . 1998 Oncogene 17: 57–68. (10.1038/sj.onc.1201905)
  65. Wang H-G, Rapp UR and Reed JC. . 1996 Cell 87: 629–638. (10.1016/S0092-8674(00)81383-5)
  66. Wang X, Martindale JL and Holbrook NJ. . 2000 J. Biol. Chem. In press.
  67. Weber CK, Slupsky JR, Herrmann C, Schuler M, Rapp UR and Block C. . 2000 Oncogene 19: 169–176. (10.1038/sj.onc.1203261)
  68. Welch DR, Sakamaki T, Pioquinto R, Leonard TO, Goldberg SF, Hon Q, Erikson RL, Rieber M, Rieber MS, Hicks DJ, Bonventre JV and Alessandrini A. . 2000 Cancer Res. 60: 1552–1556.
  69. Yuen AR and Sikic BI. . 2000 Frontiers Biosci. D588–593. (10.2741/A534)
  70. Yeung K, Seitz T, Li S, Janosch P, McFerran B, Kaiser C, Fee F, Katsanakis KD, Rose DW, Mischak H, Sedivy JM and Kolch W. . 1999 Nature 401: 173–177. (10.1038/43686)
  71. Yeung K, Janosch P, McFerran B, Rose DW, Mischak H, Sedivy JM and Kolch W. . 2000 Mol. Cell. Biol. 20: 3079–3085. (10.1128/MCB.20.9.3079-3085.2000)
  72. Yung Y, Yao Z, Hanoch T and Seger R. . 2000 J. Biol. Chem. 275: 15799–15808. (10.1074/jbc.M910060199)
  73. Zecevic M, Catling AD, Eblen ST, Renzi L, Hittle JC, Yen TJ, Gorbsky GJ and Weber MJ. . 1998 J. Cell Biol. 142: 1547–1558. (10.1083/jcb.142.6.1547)
  74. Zeneca Ltd. . 1998 WO9822103.
  75. Zhu X and Assoian RK. . 1995 Mol. Biol. Cell 6: 273–282. (10.1091/mbc.6.3.273)
Dates
Type When
Created 23 years ago (Sept. 4, 2002, 3:53 p.m.)
Deposited 3 years, 5 months ago (March 21, 2022, 8:09 p.m.)
Indexed 1 month ago (Aug. 2, 2025, 12:56 a.m.)
Issued 24 years, 8 months ago (Dec. 27, 2000)
Published 24 years, 8 months ago (Dec. 27, 2000)
Published Print 24 years, 8 months ago (Dec. 27, 2000)
Funders 0

None

@article{Sebolt_Leopold_2000, title={Development of anticancer drugs targeting the MAP kinase pathway}, volume={19}, ISSN={1476-5594}, url={http://dx.doi.org/10.1038/sj.onc.1204083}, DOI={10.1038/sj.onc.1204083}, number={56}, journal={Oncogene}, publisher={Springer Science and Business Media LLC}, author={Sebolt-Leopold, Judith S}, year={2000}, month=dec, pages={6594–6599} }